Increased PAD2 and citrullinated protein expression are observed in normal appearing white matter in the CNS of people with MS, thought to be driven by hypomethylation of the PAD2 promoter leading to increased PAD2 expression in these regions (10, 11). The gene discussed is PADI2; the disease is myeloid sarcoma.